MATSUNAGA Shinji

J-GLOBAL         Last updated: Nov 29, 2019 at 04:11
 
Avatar
Name
MATSUNAGA Shinji
Affiliation
Osaka City University
Section
Graduate School of Medicine Basic Medicine Course
Job title
Lecturer
Research funding number
30704910

Research Areas

 
 

Academic & Professional Experience

 
Jul 2016
 - 
Today
Lecturer, Graduate School of Medicine Basic Medicine Course, Osaka City University
 
Jul 2011
 - 
Apr 2013
Post Doctoral Fellow, Department of Radiation Oncology, University of Texas Southwestern Medical Center
 
Jul 2011
 - 
Apr 2013
Post Doctoral Fellow, Department of Radiation Oncology, University of Texas Southwestern Medical Center
 

Education

 
Apr 2007
 - 
Mar 2011
Graduate School, Division of Medical Sciences, Tottori University
 
Apr 2004
 - 
Mar 2006
Graduate School, Division of Pharmaceutical Sciences, Gifu Pharmaceutical University
 
Apr 2000
 - 
Mar 2004
Faculty of Pharmaceutical Science, Gifu Pharmaceutical University
 
Apr 2007
 - 
Mar 2011
Graduate School, Division of Medical Sciences, Tottori University
 
Apr 2004
 - 
Mar 2006
Graduate School, Division of Pharmaceutical Sciences, Gifu Pharmaceutical University
 

Published Papers

 
Kitajima Shojiro, Lee Kian Leong, Hikasa Hiroki, Sun Wendi, Huang Ruby Yun-Ju, Yang Henry, Matsunaga Shinji, Yamaguchi Takehiro, Araki Marito, Kato Hiroyuki, Poellinger Lorenz
ONCOTARGET   8(70) 114481-114494   Dec 2017   [Refereed]
Koyama Satoshi, Matsunaga Shinji, Imanishi Masaki, Maekawa Yoichi, Kitano Hiroya, Takeuchi Hiromi, Tomita Shuhei
SCIENTIFIC REPORTS   7 45621   Mar 2017   [Refereed]
Imanishi Masaki, Chiba Yoichi, Tomita Noriko, Matsunaga Shinji, Nakagawa Toshitaka, Ueno Masaki, Yamamoto Kazuhiro, Tamaki Toshiaki, Tomita Shuhei
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY   36(11) 2158-+   Nov 2016   [Refereed]
Li M, Lin YF, Palchik GA, Matsunaga S, Wang D, Chen BP
Free radical biology & medicine   76 278-85   Nov 2014   [Refereed]
Lin YF, Shih HY, Shang Z, Matsunaga S, Chen BP
Nucleic acids research   42(7) 4463-73   Apr 2014   [Refereed]

Misc

 
Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, Takeda N, Tomura M, Uchida J, Miura K, Nakatani T, Tomita S
iScience   19 940-954   Sep 2019   [Refereed]
Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y
Journal of pharmacological sciences   139(2) 112-119   Feb 2019   [Refereed]
Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, Takeda N, Tomura M, Uchida J, Miura K, Nakatani T, Tomita S
iScience   21 205   Nov 2019   [Refereed]
Yamaguchi Takehiro, Watanabe Ayano, Tanaka Masako, Shiota Masayuki, Osada-Oka Mayuko, Sano Soichi, Yoshiyama Minoru, Miura Katsuyuki, Kitajima Shojiro, Matsunaga Shinji, Tomita Shuhei, Iwao Hiroshi, Izumi Yasukatsu
(公社)日本薬理学会 Journal of Pharmacological Sciences   139(2) 112-119   Feb 2019   [Refereed]
DPP-4欠損ラットを用いて、DPP-4阻害剤であるリナグリプチン(LGP)の抗リモデリング効果を調べた。心筋梗塞(MI)の誘発後、DPP-4の不活性化変異を有するFischer 344ラットに、LGP(5mg/kg/day)または基剤を4日間経口投与した。LGPは血行動態、体重および梗塞サイズに影響を与えなかった。心エコー検査では、LGPは左心室(LV)の収縮機能を改善する傾向があり、LVの拡張機能を有意に改善した。辺縁領域の間質性線維症およびマクロファージ浸潤は、基剤群よりもLGP群で...